Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ... Apr 20
As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ... Nov 17
The findings not only represent a major breakthrough for Eli Lilly but also for the scientific community as a whole, proving that perseverance and dedication ... Jul 18
Treatment of mild and moderate Covid19 ... Feb 14
Latest Pharma News Update... Aug 23
Pharma merger and acquisitions... Jul 15
Facts about the Alzheimer's disease... Jul 08
Testosterone Topical Solution USP, 30 mg per pump actuation is indicated for replacement therapy in males for conditions associated with a deficiency or absence of ... Jun 17
MiNA will utilize its saRNA platform to research up to five targets selected by Lilly that aim to address diseases across Lilly's key therapeutic ... May 15
The move comes after the detection of different Covid variants ... Mar 26
The inhibitor is for the potential treatment of Immunological and Neurodegenerative diseases... Feb 22
Glenmark has also received tentative approval by the U.S. FDA for Gabapentin Enacarbil Extended-Release Tablets, the generic version of Horizant 1of Arbor Pharmaceuticals.... Dec 31
The acquisition will establish a new modality for drug discovery and development at Lilly ... Dec 15
Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020... Nov 23
This collaboration will help to accelerate the work aimed to solve genetic diseases with unique editing challenges... Nov 21
... Nov 19
Eli Lilly’s neutralizing antibody bamlanivimab receives US FDA emergency use authorization for the treatment of recently diagnosed COVID-19... Nov 12
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD.... Nov 06
Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
The company reiterated that it had not received a warning letter from the U.S. Food and Drugs Administration following inspections at the plant.... Oct 21
Eli Lilly successfully develop and commercialize new medicines resulting from the acquisition... Oct 16
The antiviral medication was one of the drugs used to treat U.S. President Donald Trump’s coronavirus infection, and has been shown in previous ... Oct 16
ELI Lilly, J & J and AstraZeneca halts covid drug trials... Oct 15
The survival rate is also relatively higher than other tumour types when having appropriate treatment... Oct 09
Drug combo cuts recurrence risk of breast cancer by 25%... Sep 21
-Advertisements-
Monday, April 29, 2024
.jpg)
